Mature B-cell Non-Hodgkin Lymphoma (DBCOND0075244)

Identifiers

Synonyms

Not Available

Associated Data

Indicated Drugs and Targets

Not Available

Clinical Trials

Identifier	Title	Drug(s)	Purpose	Phase	Status
NCT05533775	A Study to Evaluate Glofitamab Monotherapy and Glofitamab + Chemoimmunotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Mature B-Cell Non-Hodgkin Lymphoma	Carboplatin Etoposide Glofitamab Ifosfamide Obinutuzumab Rituximab Tocilizumab	treatment	1 / 2	recruiting
NCT04986865	A Study ATG-101 in Patients With Metastatic/Advanced Solid Tumors and Mature B-cell Non-Hodgkin Lymphomas	ATG-101	treatment	1	recruiting
NCT03206671	Treatment Protocol of the NHL-BFM and the NOPHO Study Groups for Mature Aggressive B-cell Lymphoma and Leukemia in Children and Adolescents	Cyclophosphamide Cytarabine Dexamethasone Doxorubicin Etoposide Ifosfamide Methotrexate Prednisolone Rituximab Vincristine Vindesine	treatment	3	recruiting
NCT02405676	BNHL-2015 for Children or Adolescents in China	Cyclophosphamide Cytarabine Etoposide Methotrexate Prednisone Rituximab Vincristine	treatment	2 / 3	active_not_recruiting
NCT05490043	A Trial of ATG-101 in Patients With Metastatic/Advanced Solid Tumors and Mature B-cell Non-Hodgkin Lymphomas	ATG-101	treatment	1	recruiting